Investment in Associate |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment in Associate [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment in associate |
On January 10, 2025, the Company closed an investment to acquire 10% of Neuronomics AG for $288,727 (CHF 262,684). On March 7, 2025, the Company announced that it increased its stake in Neuronomics AG, a Swiss asset management firm specializing in artificial intelligence and model driven quantitative trading strategies from 10% to 52.5% and Neuronomics was fully consolidated with the Company’s consolidated financial statements (Note 8). On October 1, 2025, the Company’s ownership was reduced to 44.68% and as a result, Neuronomics was deconsolidated and accounted for as an investment in associate.
The Company’s ownership of Neuronomics during the year ended December 31, 2025 was 44.68%.
A continuity of the investment in Neuronomics as an associate is as follows:
Summarized financial information for Neuronomics as at December 31, 2025 and for the year ended December 31, 2025 is as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||